2017

Merck & CDRD announced the establishment of a new $1.5M Merck-CDRD Innovation Fund. This fund will go directly towards the advancement of projects of high therapeutic potential carried out at CDRD in collaboration with academic researchers.

Thank you for your ongoing commitment to CDRD. This purpose of this note is to celebrate our successes and report to you on what we have in store.

CDRD is pleased to announce the appointments of Dr. Francois Bénard and Ms. Nancy Harrison as Directors of the organization.

Five of the world’s top translational science organizations representing the European Union, the United Kingdom, the United States, Canada, and Australia have joined forces under the new banner of Translation Together. This new collaboration will enable the leveraging of complementary scientific and operational strengths of member organizations, provide a platform to share insight of the challenges facing translation, and put forth a collective voice to advance the science and understanding of biomedical translation.

A key part of CDRD’s Mission is training the next generation of highly-qualified personnel to drive the development of new innovations. Visit our YouTube Channel to meet some of the…

JDRF announced that it will contribute funding to Canada’s Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel therapeutic approach to prevent hypoglycemia in patients with diabetes.

Sepset’s initiation of a clinical study is a significant step forward in commercializing a test for health care professionals so they can rapidly and appropriately treat a condition where minutes are the difference between life and death. Current methods to diagnose sepsis take more than 24 hours by which time patients are often well on their way towards tissue damage, organ failure, and death.